Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations

The summary for the Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations

Federal Grant Title:	Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Continuation
Funding Opportunity Number:	RFA-IP-15-00203CONT17
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.083, 93.185
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 22nd, 2017
Original Application Deadline:	March 22nd, 2017
Posted Date:	February 12th, 2017
Creation Date:	February 12th, 2017
Archive Date:	April 21st, 2017
Total Program Funding:	$0
Maximum Federal Grant Award:	$0
Minimum Federal Grant Award:	$0
Expected Number of Awards:	10
Cost Sharing or Matching:	No
Last Updated:	February 12th, 2017

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations.
Grant Announcement Contact: Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS)
Technical Information Management Section (TIMS)
Phone: 770-488-2700

[email protected]
Similar Government Grants: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Bloo...; • Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pan...; • Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia...; • Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a...; • Economic Studies of Immunization Policies and Practices
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...